These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34229704)

  • 1. Lymphocyte to C-reactive protein ratio predicts long-term outcomes for patients with lower rectal cancer.
    Nishi M; Shimada M; Tokunaga T; Higashijima J; Yoshikawa K; Kashihara H; Takasu C; Ishikawa D; Wada Y; Eto S; Yoshimoto T
    World J Surg Oncol; 2021 Jul; 19(1):201. PubMed ID: 34229704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Potential of Lymphocyte-C-Reactive Protein Ratio in Patients with Rectal Cancer Receiving Preoperative Chemoradiotherapy.
    Okugawa Y; Toiyama Y; Fujikawa H; Ide S; Yamamoto A; Omura Y; Yin C; Kusunoki K; Kusunoki Y; Yasuda H; Yokoe T; Hiro J; Ohi M; Kusunoki M
    J Gastrointest Surg; 2021 Feb; 25(2):492-502. PubMed ID: 32040814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis of locally advanced rectal cancer can be predicted more accurately using pre- and post-chemoradiotherapy neutrophil-lymphocyte ratios in patients who received preoperative chemoradiotherapy.
    Sung S; Son SH; Park EY; Kay CS
    PLoS One; 2017; 12(3):e0173955. PubMed ID: 28291841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of changes in serum carcinoembryonic antigen levels for preoperative chemoradiotherapy response in locally advanced rectal cancer.
    Cheong C; Shin JS; Suh KW
    World J Gastroenterol; 2020 Nov; 26(44):7022-7035. PubMed ID: 33311947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Neutrophil-to-lymphocyte Ratio on the Effect of CRT for Patients With Rectal Cancer.
    Ishikawa D; Nishi M; Takasu C; Kashihara H; Tokunaga T; Higashijima J; Yoshikawa K; Shimada M
    In Vivo; 2020; 34(2):863-868. PubMed ID: 32111796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of pre- to post-chemoradiotherapy s-CEA reduction ratio in rectal cancer patients treated with preoperative chemoradiotherapy and curative resection.
    Kim CW; Yu CS; Yang SS; Kim KH; Yoon YS; Yoon SN; Lim SB; Kim JC
    Ann Surg Oncol; 2011 Nov; 18(12):3271-7. PubMed ID: 21537868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-reactive protein as predictor of recurrence in patients with rectal cancer undergoing chemoradiotherapy followed by surgery.
    Toiyama Y; Inoue Y; Saigusa S; Kawamura M; Kawamoto A; Okugawa Y; Hiro J; Tanaka K; Mohri Y; Kusunoki M
    Anticancer Res; 2013 Nov; 33(11):5065-74. PubMed ID: 24222151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic Inflammatory Response After Preoperative Chemoradiotherapy Can Affect Oncologic Outcomes in Locally Advanced Rectal Cancer.
    Lee IH; Hwang S; Lee SJ; Kang BW; Baek D; Kim HJ; Park SY; Park JS; Choi GS; Kim JC; Cho SH; Kim JG
    Anticancer Res; 2017 Mar; 37(3):1459-1465. PubMed ID: 28314318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poor nutrition and sarcopenia are related to systemic inflammatory response in patients with rectal cancer undergoing preoperative chemoradiotherapy.
    Abe S; Nozawa H; Kawai K; Sasaki K; Murono K; Emoto S; Kishikawa J; Ozawa T; Yokoyama Y; Nagai Y; Anzai H; Sonoda H; Ishihara S
    Int J Colorectal Dis; 2022 Jan; 37(1):189-200. PubMed ID: 34633498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LMR predicts outcome in patients after preoperative chemoradiotherapy for stage II-III rectal cancer.
    Abe S; Kawai K; Nozawa H; Hata K; Kiyomatsu T; Morikawa T; Watanabe T
    J Surg Res; 2018 Feb; 222():122-131. PubMed ID: 29273363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of persistent lower neutrophil-to-lymphocyte ratio during preoperative chemoradiotherapy in locally advanced rectal cancer patients: A propensity score matching analysis.
    Cha YJ; Park EJ; Baik SH; Lee KY; Kang J
    PLoS One; 2019; 14(3):e0214415. PubMed ID: 30901357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy.
    Shen J; Zhu Y; Wu W; Zhang L; Ju H; Fan Y; Zhu Y; Luo J; Liu P; Zhou N; Lu K; Zhang N; Li D; Liu L
    Med Sci Monit; 2017 Jan; 23():315-324. PubMed ID: 28100902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of the preoperative chemoradiotherapy response for rectal cancer by peripheral blood lymphocyte subsets.
    Tada N; Kawai K; Tsuno NH; Ishihara S; Yamaguchi H; Sunami E; Kitayama J; Oba K; Watanabe T
    World J Surg Oncol; 2015 Feb; 13():30. PubMed ID: 25890185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic Resonance Imaging-Detected Extramural Venous Invasion in Rectal Cancer before and after Preoperative Chemoradiotherapy: Diagnostic Performance and Prognostic Significance.
    Lee ES; Kim MJ; Park SC; Hur BY; Hyun JH; Chang HJ; Baek JY; Kim SY; Kim DY; Oh JH
    Eur Radiol; 2018 Feb; 28(2):496-505. PubMed ID: 28786006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor volume reduction rate after preoperative chemoradiotherapy as a prognostic factor in locally advanced rectal cancer.
    Yeo SG; Kim DY; Park JW; Oh JH; Kim SY; Chang HJ; Kim TH; Kim BC; Sohn DK; Kim MJ
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e193-9. PubMed ID: 21605941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinoembryonic antigen as a predictor of pathologic response and a prognostic factor in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy and surgery.
    Park JW; Lim SB; Kim DY; Jung KH; Hong YS; Chang HJ; Choi HS; Jeong SY
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):810-7. PubMed ID: 19101093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocyte-to-C-Reactive Protein Ratio Predicts Prognosis in Patients With Colorectal Liver Metastases Post-hepatic Resection: A Retrospective Study.
    Utsumi M; Inagaki M; Kitada K; Tokunaga N; Kondo M; Yunoki K; Sakurai Y; Hamano R; Miyasou H; Tsunemitsu Y; Otsuka S
    Anticancer Res; 2022 Oct; 42(10):4963-4971. PubMed ID: 36191973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte-to-C-reactive protein ratio and score are clinically feasible nutrition-inflammation markers of outcome in patients with gastric cancer.
    Okugawa Y; Toiyama Y; Yamamoto A; Shigemori T; Ichikawa T; Yin C; Suzuki A; Fujikawa H; Yasuda H; Hiro J; Yoshiyama S; Ohi M; Araki T; McMillan DC; Kusunoki M
    Clin Nutr; 2020 Apr; 39(4):1209-1217. PubMed ID: 31155370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do haematological parameters such as HALP and Lymphocyte to C-reactive protein ratio predict tumor response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer?
    Yordanagil M; Bakir H; Güler Avci G; Yildirim M; Ozkan N; Ismail O
    Pol Przegl Chir; 2022 Nov; 95(3):1-5. PubMed ID: 36805993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined analysis of preoperative and postoperative lymphocyte-C-reactive protein ratio precisely predicts outcomes of patients with gastric cancer.
    Miyatani K; Sawata S; Makinoya M; Miyauchi W; Shimizu S; Shishido Y; Matsunaga T; Yamamoto M; Tokuyasu N; Takano S; Sakamoto T; Hasegawa T; Saito H; Fujiwara Y
    BMC Cancer; 2022 Jun; 22(1):641. PubMed ID: 35690739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.